Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01602692 · ClinicalTrials.gov registry record · Phase 4
A Comparison of Tumescence in Breast Reduction Surgery
A Phase 4 study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
NCT01602692 is a Phase 4 study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 40 participants.
The verdict
NCT01602692, a Phase 4 study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
Study Summary
The investigators' main hypothesis is that in breast reduction surgery, the use of tumescent solution containing both dilute lidocaine and epinephrine will lead to better control of postoperative pain, nausea, vomiting, shorter time through postoperative phases of care, quicker discharge from the hospital and lower numbers of hospital readmissions than the use of tumescent solution containing only dilute epinephrine.
Interventions
- DRUG Tumescent solution with dilute lidocaine and epinephrine
- DRUG Tumescent Solution with dilute epinephrine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2012-08 |
| Est. Completion | 2014-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01602692
The ClinicalTrials.gov registry entry for NCT01602692 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Tumescent solution with dilute lidocaine and epinephrine is the first listed.
NCT01602692 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01602692 about?
NCT01602692 is a clinical study titled "A Comparison of Tumescence in Breast Reduction Surgery". The investigators' main hypothesis is that in breast reduction surgery, the use of tumescent solution containing both dilute lidocaine and epinephrine will lead to better control of postoperative pain, nausea, vomiting, shorter time through postoperative phases of care, quicker discharge from the ho...
What is the current status of trial NCT01602692?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2012-08. Estimated completion is 2014-07.
What interventions are being tested in trial NCT01602692?
The interventions under investigation include: Tumescent solution with dilute lidocaine and epinephrine (DRUG), Tumescent Solution with dilute epinephrine (DRUG).
Who is sponsoring clinical trial NCT01602692?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.